| Ytd | -42.72% | |
| 1y | -74.96% |
| Open | 0.95 | Prev Close | 0.95 | Low | 0.92 | High | 0.98 | Mkt Cap | 64.75M |
| Vol | 17.39K | Avg Vol | 97.06K | EPS | -0.05 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.25 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 0.91 | 200-d Avg | 1.30 | 1yr Est | 0.00 |
SLSN News
Solesence's Q2 results are pressured by higher operating expenses, but improving production efficien
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Solesence (NASDAQ:SLSN) released second-quarter financial results and hosted an earnings call on Wed
Solesence (NASDAQ:SLSN) reported $15.332 million in sales this quarter. This is a 24.69 percent decr
Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure tha
ROMEOVILLE, Ill. , Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in sci
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scie
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo power
Both products are available to brand partners globally and represent a significant expansion into th
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18
SPF-Infused Concealer Featuring Kleair, WHSPR, and Chromalüm Recognized Across Anti-Aging, Color Cos
Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin impr
The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national stra
Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript
Solesence (NASDAQ:SLSN) reported quarterly losses of $(0.01) per share. The company reported $12.95
Advances implementation of Transform and Transcend strategic initiative across Operational Excellenc
New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrou
ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in sci
Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees RO
Discover why Zacks issues an "Underperform" rating for Solesence, being the first on Wall Street to
Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript
Solesence (NASDAQ:SLSN) reported $12.483 million in sales this quarter. This is a 0.67 percent decre
Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) --
